Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ted Breck


Mr. Ted Breck serves as Managing Director at TPG Biotech. Mr. Breck leads TPG's Life Sciences structured investments for mid and late-stage pharma pipeline assets, drug launches and drug royalty monetizations. Previously, Mr. Breck led the effort at TPG-Axon Capital for three years where they invested over $1.3 billion in such structured financings. Prior to joining TPG in 2005, Mr. Breck had nearly two decades of experience in healthcare investment banking at Lehman Brothers in New York and subsequently, San Francisco, where he led the firm's West Coast Life Sciences business in financing and merger and acquisition transactions. Mr. Breck received his B.A. at the University of California at Berkeley. Mr. Breck is a member of the Advisory Council of the J. David Gladstone Institutes, an independent, non-profit biomedical research organization affiliated with the University of California, San Francisco.

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)

Ted Breck Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
0000000 18-Mar-2014 0000 00000 00.00 Social/Platform Software Generating Revenue 000 00000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ted Breck’s full profile, request a free trial.

Ted Breck Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 18-Sep-2018 000000000000000000 00000 Completed
  • 00000 00000000000
To view this investor’s complete exits history, request access »

Ted Breck Team (1)

Name Title Deals Funds Boards Office Contact
Ted Breck Angel Investor 0